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Introduction
Ascorbic acid (vitamin C) is a powerful antioxidant with a number of effects on the brain including protection against oxidative damage [1], involvement in catecholamine synthesis, and possible 
neuromodulation of neural transmission viaglutamine, dopamine, acetylcholine and GABA along 
with associated behavioral responses [2]. During the last 20 years, there has been increasing interest 
in the possible anxiolytic effects of ascorbic acid supplementation even when there is no evidence of 
a deficiency in its endogenous form, namely ascorbate. For example, it has been shown that 14 days 
of treatment of normal human volunteers with 3g of ascorbic acid reduced salivary cortisol, blood 
pressure and subjective anxiety in response to a psychological stressor [3]. Ascorbic acid’s anxiolytic 
potential has also been suggested by reports of it decreasing neophobia and measures of fear in 
poultry [4,5], reducing avoidance of an aversive environment in mice [6], alleviating behavioral and 
biochemical stress responses to electroshock in mice [7], attenuating anxiogenic effects of prolonged 
exposure to loud noise in mice [8], and decreasing several forms of anxiety-related behavior in rats [9]. 
As the rats in our earlier study [9] were provided with only one level of chronic ascorbic acid in 
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their drinking water (approximately 80 mg/kg/day), one of 
the aims of the present study was to determine if doses lower 
and higher than this would have comparable anxiolytic effects.
Some evidence of dose-related effectiveness of the vitamin has 
been reported by Choi et al [7]. Therefore, effects of treatment 
with three doses of ascorbic acid on anxiety-related behavior 
were recorded in an open field and an elevated plus maze. Both 
types of apparatus are commonly used for assessing anxiety 
levels in rats [10,11].
Improved impaired memory following intraperitoneal or 
intravenous ascorbic acid administration has been illustrated 
by several examples of reduced age-related and drug-induced 
memory deficits in rats [11] and mice [6,13,14]. Such findings 
support the suggestion that ascorbic acid can protect against the 
cognitive decline accompanying neurodegenerative disorders, 
such as Alzheimer’s Disease [2,15], which are characterized by 
ascorbate deficiencies [16,17]. However, there has been signifi-
cantly less research into effects of ascorbic acid supplementation 
on unimpaired memory in healthy subjects. Of the few studies 
on record, one has shown that long-term oral administration 
(30 days) of both 60 and 120 mg/kg of the vitamin significantly 
enhanced passive avoidance learning and memory in rats [18]. 
More recently it was reported that acute intravenous ascorbic 
acid improved spatial memory in mice [19]. Therefore, a second 
aim of the present study was to assess the effects of ascorbic 
acid on recognition memory in normal rats as reflected in a 
novel object recognition task. This task involves evaluating 
preferences for a novel versus familiar object and has become a 
popular way of measuring recognition memory in rodents [20]. 
As previously [9], ascorbic acid was added to rats’ drinking water 
in quantities designed to achieve three daily doses. These were 
60 and 120 mg/kg (as administered by Shahidi et al., [18]) plus 
an additional higher dose of 180 mg/kg.
Methods
The subjects were 40 female and 40 male hooded rats of the PVG/c 
strain bred on the Animal Facility of the Department of Psychol-
ogy, University of Canterbury, Christchurch, New Zealand. They 
were weaned at 30 days of age and kept in groups of 4 same-sexed 
animals until the beginning of ascorbic acid exposure approxi-
mately 140 days later. The rats were then randomly assigned to 
a control or one of 3 ascorbic acid groups in same-sexed pairs 
in 560x350x215-mm (lengthxwidthxheight) plastic cages. The 
two members of each pair were separated from each other by a 
560x215-mm (lengthxheight) wire partitions that enabled visual, 
auditory and olfactory but not physical contact. This enabled 
individual measurements of volumes of water or ascorbic acid 
drunk (see below) without the rats being totally socially isolated. 
All cages were kept in 12 h light: 12 h dark illumination (lights 
on at 700 h) with an ambient temperature of 20±1°C. There were 
10 females and 10 males in each of the 4 groups. All animals 
had ad libitum access to standard laboratory rat food pellets. 
    All treatment and testing procedures complied with the re-
quirements of Parts 5 (Codes of Welfare) and 6 (Use of Animals 
in Research, Testing and Teaching) of the New Zealand Animal 
Welfare Act, 1999, and had been approved by the University 
of Canterbury’s Animal Ethics Committee (approval number 
2013/14R).
Preparation of and treatment with ascorbic acid 
solutions
Ascorbic acid powder was dissolved in tap water in amounts 
designed to achieve target doses of approximately 60, 120 and 
180 mg/kg/day on the basis of earlier established volumes of 
water drunk each day by individual PVG/c rats [9]. After taking 
into account differences between the two species in body surface 
area [21], these doses for rats were equivalent to 0.73, 1.45 and 
2.28 g/day of ascorbic acid for an average 75.6 kg adult human 
(based on body weight data for Europe and North America 
[22]). Doses of this magnitude are well tolerated and without 
adverse effects [23,24]. Since females typically drink more than 
males, the quantities of ascorbic acid that were added to the rats’ 
drinking water were different for each sex to ensure that they 
both consumed equivalent daily doses. The resulting drinking 
fluids were provided ad libitum up to and including the 3-day 
testing period. Every second (and occasionally third) day for the 
duration of the study, each rat was weighed and, when its drink-
ing bottle was topped up, its daily consumption of ascorbic acid 
(mg/kg) was calculated from the volume of fluid drunk since the 
last measurement. Once a week, all bottles were replaced with 
sterilized ones containing freshly prepared solutions.
Testing apparatus
Behavioral effects of treatment with ascorbic acid were measured 
in an open field (OF) and an elevated plus maze (EPM). The 
interior of the 900x900x300-mm high wooden OF was painted 
black, and the floor was divided into 16 numbered squares by 
means of a grid of intersecting white lines. A small 200x150x195 
mm (lxwxh) wooden start box, with a hinged lid, was attached 
to the outside of one wall that enabled access to the interior of 
the apparatus through a slide-controlled 100x100-mm open-
ing. The OF sat on a 700 mm-high table and was illuminated 
by overhead fluorescent room lighting.
The wooden EPM comprised four 500 mm-longx100-mm 
wide arms extending (at 90° to each other) from a central 
150-mmx150-mm platform. Two of the arms facing each 
other had 245-mm-high side and end walls comprising clear 
Perspex (the open arms) while the same walls of the other two 
were constructed from black-painted wood (the closed arms). 
Although the presence of transparent walls on the open arms 
is not conventional practice, they prevent a startled rat from 
leaping off the arm and do not appear to reduce its aversiveness 
[25] and thus anxiogenic properties [26]. The maze was evenly 
illuminated by overhead fluorescent room lighting and sat on 
a 1 m-high stand.
General procedure
After 8 weeks of ascorbic acid treatment, all rats received a 
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trial in the OF, followed the next day by a trial in the EPM, and 
finally on the third day, a novel object recognition trial (NOR). 
The responses were recorded by means of a momentary time-
sampling procedure whereby, every 3 s (indicated by an auditory 
signal and ear piece), each rat’s location in the apparatus was 
noted and, where relevant, what type of behavior it was engaged 
in. Such procedures have proved to be accurate and reliable for 
estimating frequencies and duration of events [27]. For example, 
time-sampling has been shown to produce test-retest reliability 
coefficients of between 0.93 and 0.98, and validity coefficients of 
0.87 and 0.99 [28]. All observations were made via CCTV with 
the camera above the apparatus and the monitor and observer 
situated some distance away. Following a trial, the apparatus was 
thoroughly washed and dried before the next rat’s test.
OF testing
Each rat was placed in the start box and then allowed access to 
the interior of the OF by removal of the slide. The time taken 
for the rat to fully emerge was recorded, the slide was replaced 
and then, every 3 s for 5 min, it was noted which square the 
rat was occupying and if it was engaged in one of the following 
responses: walking within or between squares (walking), stand-
ing up on its hind legs either unsupported or leaning against a 
wall (rearing), licking its body (grooming) or remaining totally 
motionless (immobile). At the same time, it was noted if the rat 
was occupying one of the four center squares (center occupancy) 
or corners (corner occupancy) of the apparatus. High frequencies 
of walking, rearing and center occupancy is regarded as indices 
of low anxiety, while high frequencies of grooming, immobility 
and corner occupancy are thought to reflect high anxiety [11,29]. 
From square occupancy data it was also possible to estimate 
distance travelled (ambulation) by counting the number of times 
the rat was in a different square from that occupied when the 
immediately preceding 3 s signal occurred [26,30,31]. At the 
completion of its trial, the rat was allowed to freely explore the 
OF for a further 5 min as additional familiarization with the 
apparatus in preparation for the NOR trial to be experienced 
on the third testing day (see below). 
EPM testing
Each rat was placed on the central platform of the apparatus 
facing one of the closed arms and continuously observed for 5 
min. Its entries (all four feet) into each arm were counted and 
every 3 s the arm being occupied by the rat was noted. It was 
subsequently possible to calculate the rat’s percentage of entries 
into the open arms and the percentage of 3 s observations when 
occupying these arms. These two measures are indicative of 
willingness to visit the anxiety-inducing unenclosed parts of 
the apparatus [10]. The total number of entries into the closed 
arms comprised a measure of locomotor activity that is relatively 
uncontaminated by anxiety [32].
NOR testing
For all rats, the familiar objects were two weighted 300-ml 
empty drink cans, 115 mm high and with a diameter of 60 mm. 
The novel object was a stop clock 115 mm high, 115 mm wide 
and 45 mm deep. In an earlier independent experiment, any 
preference for one object rather than the other (irrespective 
of their novelty values) had been assessed in 20 adult PVG/c 
hooded rats that were not part of the present study. The as-
sessment involved placing the can and stop clock in diagonal 
quadrants of an open field and, via CCTV, recording every 3 
s for 5 min, if the rat was in physical contact with and sniffing 
or manipulating either object. The position of each object was 
alternated for different rats. It was accordingly shown that the 
mean±SEM numbers of contacts made with the can and clock 
were 5.15±1.17 and 3.30±0.85 respectively. The difference between 
these values was not significant (F(1,36)=1.97, p>0.1), although 
female rats made significantly more contacts with both than 
males (females=6.20±1.12, males=2.25±0.73, F(1,36)=8.99, p<0.01).
For a NOR trial,the two cans were placed in diagonal corners 
of the OF, 10 cm from the walls. Each rat was then placed in 
the center of the OF and allowed to explore the apparatus and 
cans for 5 min after which time it was removed and returned to 
a holding cage. One of the cans was replaced by the stop clock 
(the position of which differed for different rats) and then, 15 
min later, the rat was put back into the center of the OF. Every 
3 s for 5 min it was noted if it was sniffing or manipulating the 
novel or the familiar object. A NOR discrimination index was 
calculated as follows:
 
An index greater than zero indicates more exploration of the 
novel than the familiar object, whereas an index of less than 
zero indicates the opposite [33].
Statistical analysis 
Unless stated otherwise, all data were subjected to separate 4 
(treatment)x2 (sex) ANOVAs using the StatviewTM SE II statistics 
package for Macintosh computers. Post hoc comparisons were 
made by means of Fisher PLSD tests (p<0.05).
Results
Doses, fluid drunk and body weights
Determination of the rats’ average ascorbic acid consumption 
for each of the three treatment conditions revealed approximate 
daily doses of 61, 114 and 160 mg/kg (to the nearest whole 
number). The mean±SEM volumes of average fluid drunk each 
day (ml/100 g body weight) for the control and three ascorbic 
acid groups (both sexes combined) were 9.34±1.05, 8.21±0.59, 
7.71±0.67 and 7.23±0.59 respectively. The differences between 
the groups were not significant (F(3,72)=1.46, p>0.2). However, 
for all groups combined, female rats drank significantly more 
fluid each day than males (females=10.95±0.40, males=5.30±0.11, 
F(1,72)=232.58, p<0.0001).
Respective mean±SEM body weights (g) for the control and 
three treatment groups (both sexes combined) were 298.84±20.22, 
NOR discrimination index =
novel object exploration –  
familiar object exploration
total exploration
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300.66±22.51, 291.37±20.77 and 290.20±19.54. While there 
were no significant group differences between these weights 
(F(3,72)=0.06, p>0.9), male rats were significantly heavier than 
females (F(1,72)=2180.91, p<0.0001).
Behavioral results
For ease of inspection, the effects on all responses of treatment 
with the different doses of ascorbic acid for both sexes combined 
are presented in Figures 1, 2 and 3 whereas sex differences for all 
treatment conditions combined (along with results of ANOVAs) 
are displayed in Table 1. 
OF responses
Effects of treatment with ascorbic acid for both sexes combined 
on all OF responses except emergence latencies and immobil-
ity are outlined in Figure 1. Although emergence latencies 
were not significantly affected by ascorbic acid ([control]
mean±SEM=111.45±44.60 s, 61 mg/kg/day=99.35±20.34 s, 
114 mg/kg/day=79.60±12.21 s, 160 mg/kg/day=82.45±19.25 
s, F(3,72)=0.33, p>0.8), female rats emerged significantly faster 
than males (see Table 1).
An ANOVA of immobility data was not appropriate as the 
response was observed too infrequently among ascorbic acid 
Figure 1. Mean±SEM frequencies of (A) ambulation, (B) walking, (C) rearing, (D) grooming, (E) 
center occupancy, and (F) corner occupancy recorded in the open field following treatment with 
three doses of ascorbic acid for female and male rats combined. 
*Significantly different (p<0.05) from control group. 
a,bGroups with superscripts in common significantly different (p<0.05).
A. Ambulation D. Grooming
B. Walking E. Center occupancy
C. Rearing F. Corner occupancy
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Figure 2. Mean±SEM (A) per cent occupation of the 
open arms, (B) per cent entries into the open arms, and 
(C) total entries into the closed arms of the elevated 
plus maze following treatment with three doses of 
ascorbic acid for female and male rats combined. 
*Significantly different (p<0.05) from control group. 
a,bGroups with superscripts in common significantly 
different (p<0.05).
treated rats. However, while 14 (70%) of the 20 control animals 
were seen to be immobile at least once during the test session, 
none of the rats in either the 61 or 114 mg/kg/day group, and 
only 2 (10%) in the 160 mg/kg/day group were immobile at least 
once. As shown by a chi-square test, the difference between all 
ascorbic acid-treated rats combined and control animals was 
significant (Χ(1)=41.66, p<0.001). Of the 40 females, 7 (18%) were 
immobile at least once compared with 9 (23%) of the 40 males. 
Clearly this difference was not significant (Χ(1)=0.31, p>0.5).
Neither ambulation (Figure 1A, F(3,72)=0.89, p>0.4) nor corner 
occupancy (Figure 1F, F(3,72)=0.31, p>0.8) were significantly 
affected by ascorbic acid, but a significant effect occurred for 
walking (Figure 1B, F(3,72)=12.89, p<0.0001). This was due to 
significantly higher frequencies of the response with the two 
highest doses (114 and 160 mg/kg/day) than was the case for 
either the control or lowest dose (61 mg/kg/day). Rearing was 
also significantly affected by ascorbic acid (Figure 1C, F(3,72)=6.80, 
p<0.0005) due to significantly higher frequencies in the lowest 
dose group (61 mg/kg/day) than in any other group. Although 
rats treated with the lowest dose groomed less often than those in 
any other group, the treatment effect failed to reach significance 
(Figure 1D, F(3,72)=2.58, p=0.056).
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Figure 3. Mean±SEM discrimination indices for female and 
male rats combined following treatment with three doses of 
ascorbic acid obtained from exploration of novel and familiar 
objects in the novel object recognition task. 
*Significantly different (p<0.05) from control group. 
a,bGroups with superscripts in common significantly different 
(p<0.05). 
Response Females Males F(1,72) P
Open field:
Emergence latencies 56.60 (6.68)    136.96 (25.36) 8.04 <0.006
Ambulation 58.94 (6.69)    41.50 (1.18) 66.13 <0.0001
Walking 61.52 (1.14) 62.92 (1.17) 2.11 >0.1
Rearing 31.26 (1.17) 28.26 (1.04) 3.67   0.058
Grooming 8.12 (1.52) 7.90 (0.84) 0.45 >0.5
Center occupancy 4.44 (0.42) 1.64 (0.23) 35.94 <0.0001
Corner occupancy 50.48 (1.20) 60.38 (1.21) 34.20 <0.0001
Elevated plus maze:
% open-arm observations 46.84 (1.86) 39.37 (1.88) 10.86 <0.002
% open-arm entries 47.79 (1.04) 46.13 (1.33) 1.98 >0.1
Total closed-arm entries 10.48 (0.33) 8.82 (0.37) 11.65 < 0.002
Novel object recognition:
Total object contacts 20.55 (2.10) 16.60 (1.53) 2.32 > 0.5
Discrimination index 0.33 (0.04) 0.36 (0.05) 0.01 >0.9
Table 1. Comparison of results in the open field, elevated plus maze, and novel object 
recognition test for female and male rats.
Mean±SEM values for all responses recorded in the open field and elevated plus 
maze, and novel object recognition test for female and male rats exposed to water 
or 61, 114 or 160 mg/kg/day of ascorbic acid (exposure conditions combined), plus 
results of ANOVAs for sex differences.
As shown in Table 1, female rats exhibited significantly higher 
frequencies of ambulation and center occupancy, and a sugges-
tive (but not significant) higher frequency of rearing than males. 
They also occupied the corners of the apparatus significantly 
less often than males.
EPM responses
Effects of treatment with the three doses of ascorbic acid on 
responses recorded in the EPM are shown in Figure 2.
While the effect was significant for per cent observations in 
the open arms (Figure 2A, F(3,72)=4.34, p<0.008), this was not 
so for either per cent entries into the open arms (Figure 2B, 
F(3,72)=0.90, p>0.4) or total entries into the closed arms (Figure 2C, 
F(3,72)=1.42, p>0.2). The significant effect for observations in the 
open arms was due to rats treated with 61 mg/kg/day occupying 
these arms significantly more often than rats in any other group. 
Female rats were seen significantly more often in the open arms 
and entered the closed arms more often than males (see Table 1). 
NOR
The mean±SEM total number of contacts with both objects 
for each treatment group were: control=19.95±3.75, 61 mg/kg/
day=19.60±1.99, 114 mg/kg/day=19.35±2.29, and160 mg/kg/
day=15.40±1.89, F(3,72)=0.68, p>0.5. Clearly ascorbic acid treat-
ment did not affect this measure. Effects of ascorbic acid on the 
NOR discrimination index can be seen in Figure 3.
The index was greater than zero for each group which meant 
that they all explored the novel more than the familiar object 
[33]. Mean±SEM percentages of exploration of the novel versus 
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familiar object for the control and each ascorbic acid group 
(61, 114 and 160 mg/kg/day) respectively, were 60.15±3.85, 
68.82±3.45, 63.11±3.98 and 79.47±3.07. As shown by one-sample 
t-tests (df=19), each of these percentages significantly exceeded 
the chance expectancy of 50%. However, the ascorbic acid ef-
fect on the discrimination index was significant (F(3,72)=5.68, 
p<0.002) because of the index being significantly higher for 
the 160 mg/kg/day group than for any other group (outlined 
in Figure 3). As shown in Table 1, females and males did not 
differ significantly on either total contacts with both objects or 
the discrimination index.
Discussion
Although the approximate target dose of 60 mg/kg of ascorbic 
acid was nearly achieved for the lowest dose (i.e., 61 mg/kg/
day), the doses fell short of the goals by 5% for the 120 mg/
kg (i.e., 114 mg/kg/day) and 11% for the 180 mg/kg/day (i.e., 
160 mg/kg/day) targets. However, these short-falls were trivial 
and still resulted in levels of ascorbic acid that were sufficient 
for possible dose-response relationships to be examined. They 
were equivalent to 0.59, 1.11 and 1.56 g/day, respectively for a 
human which are well within the safe range [23,24]. Although 
there was no statistically significant main effect of the treatment 
in the daily volumes of fluid drunk, the greater relative volume 
consumed by females than by male rats was consistent with 
previous findings [9,34] and was no doubt due to the females’ 
higher level of diuresis arising from their lower levels of anti-
diuretic hormones [35,36].
Even though there was evidence of anxiolytic effects of 
ascorbic acid on behavior in the OF, the doses that were effective 
in this respect depended on the particular response recorded. 
For example, frequencies of walking within or between squares 
(but not ambulation or distance traveled) were increased by 
both higher doses, whereas rearing was increased only by the 
lowest dose. It was also notable that, irrespective of dose, all 
ascorbic acid-treated rats combined were seen to be significantly 
less immobile than control subjects. However, observations in 
the open arms of the EPM were increased only by the lowest 
dose. While all these results were indicative of reduced anxiety 
[10,11,29], they clearly did not reflect a linear dose-response 
relationship. Although center and corner occupancy in the 
OF were previously increased and decreased respectively by 
80 mg/kg/day of ascorbic acid, thereby suggesting anxiolysis 
[9], neither response was affected in the present study apart 
from a significantly higher frequency of the former response 
with 160 mg/kg/day compared with 114 mg/kg/day (consistent 
with greater anxiolysis). Inspection of the results outlined for 
OF rearing and especially open-arm observations in the EPM 
suggest that, overall, 61 mg/kg/day of ascorbic acid probably 
exerted the greatest anxiolytic effect on the rats.
The shorter emergence latencies and higher frequencies of 
rearing and center occupancy, plus lower frequencies of corner 
occupancy in the OF shown by female than by male rats are con-
sistent with the view that they are the less anxious or emotionally 
reactive of the two sexes [37]. The same conclusion would apply 
to females’ higher frequencies of open-arm observations in the 
EPM. However, the higher frequencies of female OF ambulation 
and EPM closed-arm entries were probably more likely to have 
been due to their higher activity level [38].
The significantly highest NOR discrimination index with 
160 mg/kg/day of ascorbic acid suggests that this dose had 
improved the rats’ recognition memory. This outcome is in line 
with the finding that 125 mg/kg of acute intravenous ascorbic 
acid improved spatial memory in mice [19], and that 120 mg/
kg of chronic oral ascorbic acid enhanced retention of a passive 
avoidance task [18]. To our knowledge, ascorbic acid-related 
enhanced recognition memory has not been previously reported.
On balance, most of the results obtained in the OF and es-
pecially the EPM (which is generally regarded as preferable for 
measuring rodent anxiety, [39]) were consistent with anxiolytic 
effects of ascorbic acid reported by a number of previous authors 
(described in the Introduction). These effects appeared to be 
most typical of 61 mg/kg/day, which is approximately within 
the range shown previously to be anxiolytic [9]. It is therefore 
possible that doses considerably in excess of 60-80 mg/kg/day 
(i.e., 0.73-0.98 g/day for an average human) may not reliably 
exert anxiety-reducing effects. However, a different conclusion 
seems appropriate for enhancement of recognition memory 
as this only occurred with a dose of 180 mg/kg/day. Although 
such a chronic intake that typified the present study is clearly 
not therapeutically realistic as treatment for human anxiety or 
memory disorders, the common practice for many people to 
consume vitamin C daily for other health-related reasons might 
also help protect anxiety-prone individuals from deleterious 
psychological effects of stress and/or provide some protection 
from disease- or age-related memory impairment.
While the mechanism for ascorbic acid’s anxiolytic action re-
mains to be conclusively established, possibilities include NMDA 
antagonism [40], ascorbate-related reduction of brain oxidative 
stress (that has been implicated in anxiety, [41]) and serotonin 
regulation [42]. Alternatively, ascorbic acid-induced anxiolysis 
might merely be due to attenuation of the stress hormone, cortisol 
[3,5]. Although ascorbic acid’s memory-enhancing effects have 
also been related to its antioxidant properties [43], there is evi-
dence that it functions as a modulator of brain neurotransmitters 
that are important for memory, such as acetylcholine, dopamine, 
glutamate and GABA [2]. Since, contrary to its anxiolytic action, 
ascorbic acid improved recognition of a novel object only with 
the highest dose, it is likely that different central mechanisms 
are involved in the vitamin’s effects on anxiety and memory. 
Clearly, further research is required to firmly establish critical 
doses for anxiolytic and memory-enhancing effects of ascorbic 
acid, as well as the central mechanisms responsible. 
Conclusions
The effects of chronic ascorbic acid treatment on OF walking, 
rearing and immobility, and occupation of the EPM open 
arms in rats confirmed the anxiolytic nature of the substance 
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suggested in previous research. In this respect, the lowest dose 
of 61 mg/kg/day appeared to be the most effective. However, 
only the highest dose of 160 mg/kg/day improved recognition 
memory as measured by the NOR test. From observations of 
their anxiety-related behavior and consistent with previous 
findings, female rats were less anxious (or emotionally reactive) 
than males. Overall, it was clear from the results of the present 
study that more research is required to establish critical doses for 
both the anxiolytic and memory-enhancing effects of ascorbic 
acid, and determine associated central mechanisms. 
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